Literature DB >> 8243441

The initial development of a health-related quality of life model as an outcome measure in epilepsy.

G A Baker1, D F Smith, M Dewey, A Jacoby, D W Chadwick.   

Abstract

Patients with refractory epilepsy, despite no fixed physical deficit, are often socially and psychologically handicapped. Currently available outcome measures for epilepsy do not adequately address these manifestations or their influence on well-being and quality of life. A patient-based health-related quality of life (HRQL) model for epilepsy including physical, social and psychological domains was constructed. It contains previously validated measures of anxiety, depression, happiness, overall mood, self-esteem, mastery, social satisfaction and general health and a specifically designed seizure severity scale with patient- and carer-based components. The psychometric properties of this model were evaluated in the context of the trial of a potential new antiepileptic drug. All the scales, except the Social Problems Questionnaire, have acceptable internal consistency (alpha 0.69-0.85) in this patient population. Construct validity is indicated by the ability of the scales to differentiate between groups of patients predicted to have different levels of psychosocial function. Treatment effects were detected by the patient (P = 0.017) and carers (P = 0.035) subscales of the seizure severity scale, the happiness (P = 0.003) and the mastery (P = 0.003) scales. Despite obvious deficiencies preliminary analyses are encouraging. This model provides a framework for investigating the complex interaction between the physical, social and psychological manifestations of epilepsy. The model has potential as an outcome measure for use in longitudinal studies and as a measure of disability for use in cross-sectional studies designed to compare quality of life in different populations of people with epilepsy.

Entities:  

Mesh:

Year:  1993        PMID: 8243441     DOI: 10.1016/0920-1211(93)90041-5

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  23 in total

Review 1.  Quality of life and neurological illness: a review of the literature.

Authors:  R Murrell
Journal:  Neuropsychol Rev       Date:  1999-12       Impact factor: 7.444

Review 2.  Assessing quality of life in patients with epilepsy.

Authors:  A Jacoby
Journal:  Pharmacoeconomics       Date:  1996-05       Impact factor: 4.981

3.  Directions for future research. Health related quality of life in epilepsy.

Authors:  R D Hays
Journal:  Qual Life Res       Date:  1995-04       Impact factor: 4.147

4.  The contribution of the measurement of seizure severity to quality of life research.

Authors:  D Smith; G A Baker; A Jacoby; D W Chadwick
Journal:  Qual Life Res       Date:  1995-04       Impact factor: 4.147

Review 5.  Quality of life as an outcome measure for epilepsy clinical trials.

Authors:  J A Cramer
Journal:  Pharm World Sci       Date:  1997-10

6.  Comparing drug treatments in epilepsy.

Authors:  David Chadwick; Arif Shukralla; Tony Marson
Journal:  Ther Adv Neurol Disord       Date:  2009-05       Impact factor: 6.570

7.  Adaptation and evaluation of the Liverpool Seizure Severity Scale and Liverpool Quality of Life battery for American epilepsy patients.

Authors:  S Rapp; S Shumaker; T Smith; P Gibson; R Berzon; R Hoffman
Journal:  Qual Life Res       Date:  1998-08       Impact factor: 4.147

8.  Reliability and Validity of the Korean Version of QOLIE-10 in Epilepsy.

Authors:  Sang-Ahm Lee; Sung-Cheol Yun; Byung-In Lee
Journal:  J Clin Neurol       Date:  2006-12-20       Impact factor: 3.077

9.  Adaptation and evaluation of the Liverpool Seizure Severity Scale and Liverpool Quality of Life battery for American epilepsy patients.

Authors:  S Rapp; S Shumaker; T Smith; P Gibson; R Berzon; R Hoffman
Journal:  Qual Life Res       Date:  1998-05       Impact factor: 4.147

10.  The proxy problem: child report versus parent report in health-related quality of life research.

Authors:  N C Theunissen; T G Vogels; H M Koopman; G H Verrips; K A Zwinderman; S P Verloove-Vanhorick; J M Wit
Journal:  Qual Life Res       Date:  1998-07       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.